Parkman Healthcare Partners LLC Mannkind Corp Transaction History
Parkman Healthcare Partners LLC
- $746 Million
- Q2 2025
A detailed history of Parkman Healthcare Partners LLC transactions in Mannkind Corp stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 1,900,918 shares of MNKD stock, worth $6.96 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
1,900,918
Previous 2,493,836
23.78%
Holding current value
$6.96 Million
Previous $12.5 Million
43.32%
% of portfolio
0.95%
Previous 1.63%
Shares
23 transactions
Others Institutions Holding MNKD
# of Institutions
248Shares Held
161MCall Options Held
1.24MPut Options Held
183K-
Black Rock Inc. New York, NY22.6MShares$82.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$66.5 Million0.0% of portfolio
-
State Street Corp Boston, MA10.7MShares$39.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.62MShares$27.9 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY7.01MShares$25.7 Million4.77% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $942M
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...